Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Apimeds Pharmaceuticals US Inc (APUS)

Apimeds Pharmaceuticals US Inc (APUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Apimeds Pharmaceuticals US Inc 100 MATAWAN RD SUITE 325 MATAWAN NJ 07747 USA

www.apimedsus.com Employees: 2 P: 848-201-5010

Sector:

Medical

Description:

Apimeds Pharmaceuticals US Inc. operates as a clinical stage biopharmaceutical company. It researches, develops, manufactures, commercializes and sells Apitox, an active pharmaceutical ingredient for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis. Apimeds Pharmaceuticals US Inc. is based in Hopewell, New Jersey.

Key Statistics

Overview:

Market Capitalization, $K 17,477
Enterprise Value, $K 17,477
Shares Outstanding, K 12,576
Float, K 12,576
% Float 100.00%
Short Interest, K 50
Short Float 0.40%
Days to Cover 1.00
Short Volume Ratio 0.37

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -1,390 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,780 K
EBIT, $ -5,140 K
EBITDA, $ -5,140 K

Growth:

1-Year Return -36.83%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.14 on 11/12/25
Next Earnings Date 04/21/26
Earnings Per Share ttm -0.45
EPS Growth vs. Prev Qtr 46.15%
EPS Growth vs. Prev Year 182.64%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

APUS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -139.57%
Return-on-Assets % -102.78%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.39
Book Value/Share 0.65
Interest Coverage -10.58
60-Month Beta N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar